Show simple item record

dc.contributor.authorBliss, J
dc.contributor.authorPorta, N
dc.contributor.authorEmson, M
dc.contributor.authorMiller, S
dc.contributor.authorMorden, J
dc.date.accessioned2022-01-18T15:16:01Z
dc.date.available2022-01-18T15:16:01Z
dc.date.issued2022-04-01
dc.identifier.citationClinical Cancer Research
dc.identifier.issn1078-0432
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4965
dc.language.isoeng
dc.publisherAmerican Association for Cancer Research
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserved
dc.titleCombined Peri-operative Lapatinib and Trastuzumab in Early HER2 Positive Breast Cancer can Identify Early Responders: Results from the UK EPHOS-B Trial (CRUK/08/002
dc.typeJournal Article
dcterms.dateAccepted2021-12-20
rioxxterms.versionAM
rioxxterms.licenseref.startdate2021-12-20
dc.relation.isPartOfClinical Cancer Research
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit
pubs.publication-statusAccepted
pubs.embargo.termsNot known
icr.researchteamClinical Trials & Statistics Unit
dc.contributor.icrauthorBliss, Judith
dc.contributor.icrauthorPorta, Nuria
dc.contributor.icrauthorEmson, Marie


Files in this item

Thumbnail
Thumbnail

This item appears in the following collection(s)

Show simple item record